DiagnoCure Inc. (CUR) - Product Pipeline Analysis

Document Sample
DiagnoCure Inc. (CUR)  - Product Pipeline Analysis Powered By Docstoc
					                                            DiagnoCure Inc. (CUR) - Product Pipeline Analysis

     Reference Code: GDME2210PD                                                                                                   Publication Date: NOV 2010



     Company Snapshot                                                           Company Overview
     Key Information
                                                                                DiagnoCure Inc. (DiagnoCure) is engaged in the development,
     DiagnoCure Inc., Key Facts                                                 production and commercialization of immunoassay and molecular tests
                                                                                for the detection and management of cancer. The company
     Web Address                              www.diagnocure.com
                                                                                commercializes high-value cancer diagnostic tests and lab services that
     Turnover (in USD Million)                1.50                              increase clinician and patient confidence in making critical treatment
                                                                                decisions. The product portfolio of the company includes ImmunoCyt /
     Number of Employees                      44                                uCyt+ and uPM3. It acquired lead proprietary prognostic tests with
     Industry                                 Pharmaceuticals and Healthcare-   applications in five tumor types, including breast and colon. DiagnoCure
     Source:Primary / Secondary Research                                        is collaborated with various international companies for the development
     GlobalData                                                                 and commercialization of its products.



     DiagnoCure Inc. Pipeline Products

      DiagnoCure Inc. Key Pipeline Products by Equipment                        DiagnoCure Inc. Key Pipeline Products by Therapy Area
      Type
     Equipment Type                           No of Products                    Therapy Area                                           No of Products
     Immuno Chemistry                                8                          Colorectal cancer                                             3
     Source: Primary / Secondary Research                                       Breast cancer                                                  1
     GlobalData
                                                                                Gastric cancer                                                 1
                                                                                Lung cancer                                                    1
                                                                                Melanoma                                                       1
                                                                                Prostate cancer                                                1
                                                                                Source: Primary / Secondary Research
                                                                                GlobalData




     DiagnoCure Inc. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                         No of Products
     Clinicals                                                                                                          4
     Pre-Clinicals                                                                                                     -
     Early development                                                                                                 4
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'



     DiagnoCure Inc. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                                 No of Products
     Phase IV                                                                                                          -
     Phase III                                                                                                         -
     Phase II                                                                                                          -
     Phase I                                                                                                           -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'




DiagnoCure Inc. (CUR) - Product Pipeline Analysis                                                                                     Reference Code: GDME2210PD

Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Key Facts ............................................................................................................................................................................................................................................................................... 4
     DiagnoCure Inc. - Major Products and Services .................................................................................................................................................................................................................... 5
           DiagnoCure Inc. Pipeline Products by Equipment Type.................................................................................................................................................................................................. 6
           DiagnoCure Inc. Pipeline Products by Development Stage ............................................................................................................................................................................................ 8
           DiagnoCure Inc. Pipeline Products by Therapy Area .................................................................................................................................................................................................... 10
           Breast-Shc Prognostic Test ........................................................................................................................................................................................................................................... 12
                 Product Status......................................................................................................................................................................................................................................................... 12
                 Product Description ................................................................................................................................................................................................................................................. 12
           Colorectal Shc prognostic test ....................................................................................................................................................................................................................................... 12
                 Product Status......................................................................................................................................................................................................................................................... 12
                 Product Description ................................................................................................................................................................................................................................................. 12
           Colorectal-GCC Monitoring test..................................................................................................................................................................................................................................... 13
                 Product Status......................................................................................................................................................................................................................................................... 13
                 Product Description ................................................................................................................................................................................................................................................. 13
           Lung Cancer prognostic marker test.............................................................................................................................................................................................................................. 13
                 Product Status......................................................................................................................................................................................................................................................... 13
                 Product Description ................................................................................................................................................................................................................................................. 13
           Prostate Prognostic Marker Assay ................................................................................................................................................................................................................................ 13
                 Product Status......................................................................................................................................................................................................................................................... 13
                 Product Description ................................................................................................................................................................................................................................................. 14
           Shc Gatric cancer Test .................................................................................................................................................................................................................................................. 14
                 Product Status......................................................................................................................................................................................................................................................... 14
                 Product Description ...............................................................................................................................................................................................................................
				
DOCUMENT INFO
Description: DiagnoCure Inc. (CUR) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the DiagnoCure Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to B
BUY THIS DOCUMENT NOW PRICE: $750 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.